IOVANCE BIOTHERAPEUTICS Trademark
IOVANCE BIOTHERAPEUTICS is a USPTO trademark filed by Iovance Biotherapeutics, Inc.. Status: Registered.
Trademark Facts
| Mark | IOVANCE BIOTHERAPEUTICS |
|---|---|
| Serial Number | 90398613 |
| Registration Number | 7922016 |
| Status | Registered |
| Filing Date | 2020-12-21 |
| Registration Date | 2025-08-26 |
| Mark Type | Word |
| Nice Classes | 038 (Telecommunications), 042 (Software & IT) |
| Owner | Iovance Biotherapeutics, Inc. |
| Attorney of Record | Carla B. Oakley |
| Prosecution Events | 57 |
| Latest Event | ARAA on 2026-04-07 |
Goods & Services
telecommunications services, namely, transmission of data and graphics between healthcare providers via global and local computer networks in the fields of telehealth and telemedicine; "BIOTHERAPEUTICS"; providing temporary use of non-downloadable computer software for scheduling and tracking medical patient appointments, medical laboratory services, medical procedures, and for use in providing data analytics in the fields of medical research, cancer treatments and drug and immunotherapy development; software as a service (SaaS) services featuring software for tracking and monitoring chain of custody and chain of identity of cell therapies; providing medical and scientific research information in the field of drug development and medical treatment development for delivering streamlined treatment information and improving communication among stakeholders in providing medical treatment; providing medical and scientific research information in the fields of medical research and cancer treatments; software as a service (SAAS) services featuring software for collecting, organizing, obtaining, and managing patient information, facilitating and handling communications between patients and providers, and providing advice and referrals in the fields of medicine, medical care, and healthcare; platform as a service (PAAS) featuring computer software platforms for online collecting, organizing, obtaining, and managing patient information, facilitating and handling communications between patients and providers; software as a service (SAAS) services featuring software for managing the supply of tumor shippers, temperature monitors and GPS trackers provided to sites involved in the provision of immunotherapy treatments and cancer treatments